33.53USD+0.36%Mkt Cap: 20.83B $P/E: 26.31Today
Genmab A/S, a biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark. The company markets EPKINLY and TEPKINLY for adult patients with rel…
Industry Peers
Biotechnology$139.84BUSDP/E 32.2
$85.11BUSDP/E 20.4
$69.62BUSD
$60.19BUSDP/E 39.1
$45.16BUSDP/E 19.2
$46.01BUSD
$41.76BUSDP/E 66.2
$35.67BUSDP/E 33.2
$32.46BUSDP/E 42.3
$28.53BUSD
$26.14BUSD
$25.79BUSDP/E 16.2
$17.03BUSDP/E 20.0
$16.41BUSD
$13.48BUSDP/E 17.1
$13.42BUSDP/E 187.4
$12.87BUSDP/E 264.5
$12.59BUSD
$12.48BUSD
$12.21BUSDP/E 31.6
Key Statistics
Company
Market Cap20.83B $
Enterprise Value23.72B $
Revenue (TTM)4.13B $
Gross Profit3.48B $
Net Income (TTM)963.00M $
Revenue/Share6.706 USD
Last Price33.53 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees3.1K
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)26.31
P/E (Forward)21.01
PEG6.03
EV/EBITDA17.22
EV/Revenue5.74
P/S4.97
P/B3.35
EPS (TTM)1.27
EPS (Forward)1.59
52W Range
33.2058% of range33.77
52W High33.77 USD
52W Low33.20 USD
Profitability
Gross Margin93.60%
Oper. Margin35.24%
EBITDA Margin33.33%
Profit Margin25.89%
ROE16.47%
ROA7.48%
Growth
Revenue Growth24.90%
Earnings Growth-9.40%
Cash Flow & Leverage
Operating CF1.19B $
CapEx (TTM)55.00M $
FCF Margin21.08%
FCF Yield4.18%
Net Debt3.76B $
Net Debt/EBITDA2.73
Balance Sheet
Debt/Equity0.93
Current Ratio2.46
Quick Ratio2.44
Book Value/Sh9.978 USD
Cash/Share2.529 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split5:1
Split DateMay 1, 2018
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)38.84 USD
Upside (mean)+15.8%
Target Range32.00 USD – 43.20 USD
$32.00+15.8% to mean$43.20
# Analysts11
Ownership
Shares Out.623.53M
Float589.61M
Insiders0.00%
Institutions16.87%
Short Interest
Short Ratio3.6d
Short % Float1.20%
Short % Out.1.18%
Shares Short7.39M
Short (prev mo.)8.33M
Technical
SMA 5028.41 (+18.0%)
SMA 20029.09 (+15.3%)
Beta0.69
S&P 52W Chg21.00%
Avg Vol (30d)6.35M
Avg Vol (10d)3.35M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—